This inventor holds 2 USPTO granted patents. Top assignee: Praxis Precision Medicines, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Preetam Ghogale: Innovator in Calcium Channel Modulation
Introduction
Preetam Ghogale is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of medicine, particularly in the development of formulations for T-type calcium channel modulators. His work aims to address various neurological and psychiatric disorders.
Latest Patents
Preetam Ghogale holds 2 patents related to his innovative formulations. His latest patents focus on dosage forms and compositions that are useful for preventing and treating diseases associated with aberrant function of T-type calcium channels. These conditions include epilepsy and its syndromes, tremors, and mood disorders. The inventions also encompass methods for modulating the function of T-type calcium channels, providing potential therapeutic avenues for patients suffering from these conditions.
Career Highlights
Preetam Ghogale is currently associated with Praxis Precision Medicines, Inc. His work at the company emphasizes the importance of innovative solutions in the treatment of complex medical conditions. His research and inventions have the potential to significantly impact the lives of individuals affected by neurological disorders.
Collaborations
Throughout his career, Preetam has collaborated with esteemed colleagues, including Margaret S. Lee and Sapna Makhija Garad. These collaborations have fostered a productive environment for innovation and research in the field of calcium channel modulation.
Conclusion
Preetam Ghogale is a distinguished inventor whose work in T-type calcium channel modulation holds promise for advancing medical treatments. His contributions to the field are noteworthy and reflect his commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile